journal article·2026-02-17Open access

A Stimuli-Responsive Hybrid Platform for the On-Demand Delivery of Vitamin B12

Sara Huerta-Cebollada, Jesús Antonio Fuentes-García

Applied Sciences· Volume 16· Issue 4

Abstract

Physically triggered drug release is an emerging field focused on developing materials capable of modulating release kinetics in response to external stimuli. In this work, we present a strategy for the fabrication and evaluation of heat-mediated drug release from electrospun fibers composed of a polyacrylonitrile (PAN) and poly (methyl vinyl ether-alt-maleic acid) (PMA-MVE) blend, encapsulating vitamin B12 (B12-NFs) as a model. Following thermal treatments at 90, 120, and 180 °C, results from SEM, TGA, DSC, and FTIR confirmed that increasing the crosslinking temperature promoted the formation of a more hydrophobic matrix (contact angle > 150°), which effectively reduced spontaneous drug leakage. As a proof-of-concept, we evaluated the sensitivity of the elaborated B12 to heating in aqueous media using UV-Vis spectrometry. The results indicate that the release kinetics followed a sigmoidal profile governed by the dissolution Gompertz model. This laboratory-scale evaluation establishes the fundamental mechanisms for magnetically triggered platforms based on polymeric blends, providing a robust framework for the design of remotely activated, non-invasive drug delivery platforms.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Folate and B Vitamins Research · Porphyrin Metabolism and Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC, Universidad de Zaragoza, 50009 Zaragoza, Spain

References (62)

Show source-provided references
1. Placha, D., and Jampilek, J. (2021). Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics, 13.10.3390/pharmaceutics13010064 ↗
2. Liu, J., Ting, J.P., Al-Azzam, S., Ding, Y., and Afshar, S. (2021). Therapeutic advances in diabetes, autoimmune, and neurological diseases. Int. J. Mol. Sci., 22.10.3390/ijms22062805 ↗
3. Complement, a target for therapy in inflammatory and degenerative diseases10.1038/nrd4657 ↗
4. Helminth-derived biomacromolecules as therapeutic agents for treating inflammatory and infectious diseases: What lessons do we get from recent findings?10.1016/j.ijbiomac.2023.124649 ↗
5. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity10.1002/wnan.1758 ↗
6. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects10.1016/j.medidd.2022.100134 ↗
7. Cheng, X., Xie, Q., and Sun, Y. (2023). Advances in nanomaterial-based targeted drug delivery systems. Front. Bioeng. Biotechnol., 11.10.3389/fbioe.2023.1177151 ↗
8. Review on metal nanoparticles as nanocarriers: Current challenges and perspectives in drug delivery systems10.1007/s42247-021-00335-x ↗
9. Unlocking the potential and versatility of quantum dots: From biomedical to environmental applications and smart micro/nanorobots10.1002/admi.202300970 ↗
10. Organic and inorganic nanomaterials: Fabrication, properties and applications10.1039/D3RA01421E ↗
11. Tailored mesoporous inorganic biomaterials: Assembly, functionalization, and drug delivery engineering10.1002/adma.202005215 ↗
12. Inorganic nanomaterials with rapid clearance for biomedical applications10.1039/D0CS00461H ↗
13. Recent advances in biopolymer based electrospun nanomaterials for drug delivery systems10.1002/pat.6309 ↗
14. Recent advances in nanomaterial-based drug delivery systems10.1016/j.nanoso.2024.101103 ↗
15. Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science10.1016/j.jddst.2021.102487 ↗
16. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment10.1016/j.mtbio.2022.100223 ↗
17. Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy10.1080/10717544.2021.2021324 ↗
18. Application of nanomaterials in development of electrochemical sensors and drug delivery systems for anticancer drugs and cancer biomarkers10.1080/10408347.2020.1808442 ↗
19. Nano-drug delivery systems based on natural products10.2147/IJN.S443692 ↗
20. A review on electrospun nanofibers for multiple biomedical applications10.1002/pat.5896 ↗
21. Gelatin nanofibers: Recent insights in synthesis, bio-medical applications and limitations10.1016/j.heliyon.2023.e16228 ↗
22. Nanofibers for the immunoregulation in biomedical applications10.1007/s42765-022-00191-2 ↗
23. Electrospun nanofibrous membrane for biomedical application10.1007/s42452-022-05056-2 ↗
24. Nirwan, V.P., Kowalczyk, T., Bar, J., Buzgo, M., Filová, E., and Fahmi, A. (2022). Advances in electrospun hybrid nanofibers for biomedical applications. Nanomaterials, 12.10.3390/nano12111829 ↗
25. A systematic review on green and natural polymeric nanofibers for biomedical applications10.1016/j.ijbiomac.2024.130135 ↗
26. Molecular targeted therapy for anticancer treatment10.1038/s12276-022-00864-3 ↗
27. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives10.1038/s41392-021-00572-w ↗
28. Janczura, M., Sip, S., and Cielecka-Piontek, J. (2022). The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients. Pharmaceutics, 14.10.3390/pharmaceutics14040834 ↗
29. Architectural design of block copolymers10.1021/acs.macromol.3c01730 ↗
30. Biomimetic electrospun nanofibers for tissue regeneration10.1088/1748-6041/1/3/R01 ↗
31. Electrospinning of polymer nanofibers for tissue regeneration10.1016/j.progpolymsci.2014.12.001 ↗
32. Tailoring micro/nano-fibers for biomedical applications
33. Preparation of fibers with nanoscaled morphologies: Electrospinning of polymer blends10.1002/pen.10799 ↗
34. Nagam Hanumantharao, S., and Rao, S. (2019). Multi-functional electrospun nanofibers from polymer blends for scaffold tissue engineering. Fibers, 7.10.3390/fib7070066 ↗
35. Electrospinning for drug delivery applications: A review10.1016/j.jconrel.2021.03.033 ↗
36. Electrospinning: A promising technique for drug delivery systems10.1515/rams-2020-0041 ↗
37. Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery10.1016/j.addr.2009.07.007 ↗
38. Polymeric nanofibers for drug delivery applications: A recent review10.1007/s10856-022-06700-4 ↗
39. Photoactivatable nanogenerators of reactive species for cancer therapy
40. Mechanisms for tuning engineered nanomaterials to enhance radiation therapy of cancer10.1002/advs.202003584 ↗
41. Reactive oxygen species-sensitive polymeric nanocarriers for synergistic cancer therapy10.1016/j.actbio.2021.05.023 ↗
42. Recent progress in nanostructured smart drug delivery systems for cancer therapy: A review10.1021/acsabm.2c00002 ↗
43. Substituted Poly (Methyl Vinyl Ether-alt-Maleic Anhydride) for the Release Control and Targeting of Methotrexate10.1002/(SICI)1521-4184(199811)331:11<347::AID-ARDP347>3.0.CO;2-N ↗
44. Poly (methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization10.1002/marc.201300868 ↗
45. Development of Poly (Methyl vinyl ether-alt-maleic acid) Microneedles for Transdermal Delivery of Atorvastatin Calcium10.2174/1389201021666200217103302 ↗
46. Optimization of Poly (methyl vinyl ether-co-maleic acid) Electrospun Nanofibers as a Fast-Dissolving Drug Delivery System10.4103/abr.abr_83_17 ↗
47. Poly (methyl vinyl ether-alt-maleic acid) and ethyl monoester as building polymers for drug-loadable electrospun nanofibers10.1038/s41598-017-17542-4 ↗
48. Characterisation of Blends Based on Hydroxyethylcellulose and Maleic Acid-alt-Methyl Vinyl Ether10.1002/macp.200500069 ↗
49. Dynamic Bond Chemistry in Soft Materials: Bridging Adaptability and Mechanical Robustness10.1021/acs.chemrev.5c00566 ↗
50. A pH/Temperature-Sensitive s-IPN Based on Poly (vinyl alcohol), Poly (vinyl methyl ether-alt-maleic acid) and Poly (vinyl methyl ether) Prepared by Autoclaving10.1007/s13233-022-0044-6 ↗
51. Antimicrobial hydrogels based on autoclaved poly (vinyl alcohol) and poly (methyl vinyl ether-alt-maleic anhydride) mixtures for wound care applications10.1039/C6RA08234C ↗
52. Dual-Polymeric Resin Based on Poly (methyl vinyl ether-alt-maleic anhydride) and PAMAM Dendrimer as a Versatile Supramolecular Adsorbent10.1021/acsapm.0c01254 ↗
53. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles10.1016/S0378-5173(02)00182-5 ↗
54. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties10.1016/S0168-3659(03)00066-X ↗
55. Bioadhesive poly (methyl vinyl ether-co-maleic anhydride)-TPGS copolymer modified PLGA/lipid hybrid nanoparticles for improving intestinal absorption of cabazitaxel10.1016/j.ijpharm.2021.121301 ↗
56. Magnetic nanofibers for remotely triggered catalytic activity applied to the degradation of organic pollutants10.1016/j.matdes.2023.111615 ↗
57. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
58. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets10.1021/js960473x ↗
59. Investigation of the chemical changes during thermal treatment of polyacrylonitrile and 15N-labelled polyacrylonitrile by means of in-situ FTIR and 15N NMR spectroscopy10.1016/j.polymdegradstab.2017.10.018 ↗
60. Separator membrane from crosslinked poly (vinyl alcohol) and poly (methyl vinyl ether-alt-maleic anhydride)10.3390/nano5020398 ↗
61. Pore size and flux behavior of polyvinylidene fluoride and polymethyl vinyl ether-alt-maleic anhydride with TiO210.1016/j.cej.2013.09.037 ↗
62. Chemical reactions and reactivity of primary, secondary, and tertiary diamines with acid functionalized polymers10.1002/pola.1992.080300811 ↗